| N(6)-[H2N-NLFQVVHNSYNRPAYSPG-N-\{54-amino-7,10,18,21,29,32,40,43,51,54-decaoxo-3,14,25,36,47-pentakis-[5-(\{2-[alpha-L-Rhap-(1->3)-beta-D-GlcpO]ethyl\}sulfinyl)pentanoyl]-3,6,11,14,17,22,25,28,33,36,39,44,47,50-tetradecaazatetrapentacont-1-yl\}]adipamido group (CHEBI:132682) |
| Annotations: Rat: (0) Mouse: (0) Human: (0) Chinchilla: (0) Bonobo: (0) Dog: (0) Squirrel: (0) Pig: (0) |
| Parent Terms |
Term With Siblings |
Child Terms |
|
|
->3)-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->3)]-beta-D-Galp-yl group
->4)-alpha-D-GalNAc-(1->6)-alpha-D-GlcN-(1->4)-alpha-D-(1->3)-[alpha-D-GalN-(1->4)-alpha-D-GalA-(1->7)-alpha-LD-Hep-(1->7)]-[beta-D-Glc-(1->2)]-alpha-LD-Hep-(1->3)-[beta-D-Gal-(1->4)]-alpha-LD-Hep-(1->5)-alpha-Kdo
->4)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-yl group +
->8)-alpha-Neu5Ac-(2->3)-[beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)]-beta-D-Gal-(1->4)-yl group +
3-oxo-Delta(4)-steroid group +
3-oxo-Delta(5)-steroid group
3beta-hydroxy-Delta(5)-steroid group
9-(2-O-methyl-alpha-L-rhamnosyloxy)nonanoylamino group
abasic DNA-protein cross-linked residue +
beta-D-GalpNAc-(1->4)-[alpha-Neup5Gc-(2->3)]-beta-D-Galp-(1->4)-R group +
beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-R group +
N(6)-[alpha-L-Rhap-(1->3)-beta-D-Glcp-yl]adipamido group
N(6)-[H2N-NLFQVVHNSYNRPAYSPG-N-\{54-amino-7,10,18,21,29,32,40,43,51,54-decaoxo-3,14,25,36,47-pentakis-[5-(\{2-[alpha-L-Rhap-(1->3)-beta-D-GlcpO]ethyl\}sulfinyl)pentanoyl]-3,6,11,14,17,22,25,28,33,36,39,44,47,50-tetradecaazatetrapentacont-1-yl\}]adipamido group An organic group consisting of an H2N-NLFQVVHNSYNRPAYSPG-N-{54-amino-7,10,18,21,29,32,40,43,51,54-decaoxo-3,14,25,36,47-pentakis-[5-({2-[alpha-L-Rhap-(1->3)-beta-D-GlcpO]ethyl}sulfinyl)pentanoyl]-3,6,11,14,17,22,25,28,33,36,39,44,47,50-tetradecaazatetrapentacont-1-yl} group linked to the terminal N of an adipamido group. PMID:27091615 reports several of these being linked to the CRM197 immunogenic carrier protein to form a semisynthetic glycoconjugate.
organic pentavalent group
organic tetravalent group +
organic univalent group +
P-\{alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-6-yl\}-alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-P-6-[CH2]5NHC(=O)[CH2]4C(=O)NHR group
polypeptide-derived cofactor +
|
|
 |
| Synonyms |
| Exact Synonyms: |
(1-{[3-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl]oxy}-20,31,42,53-tetrakis{5-[(2-{[3-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl]oxy}ethyl)sulfinyl]pentanoyl}-3-oxido-8,13,16,24,27,35,38,46,49,57,60,62-dodecaoxo-9-{2-[( L-asparaginyl-L-leucyl-L-phenylalanyl-L-glutaminyl-L-valyl-L-valyl-L-histidyl-L-asparaginyl-L-seryl-L-tyrosyl-L-asparaginyl-L-arginyl-L-prolyl-L-alanyl-L-tyrosyl-L-seryl-L-prolylL-prolylglycyl)amino]ethyl}-3lambda(4)-thia-9,12,17,20,23,28,31,34,39,42,45,50,53,56,61-pentadecaazahexahexacontan-66-yl)amino
|
| Related Synonyms: |
(1-{[3-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-20,31,42,53-tetrakis{5-[(2-{[3-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}ethyl)sulfinyl]pentanoyl}-3-oxido-8,13,16,24,27,35,38,46,49,57,60,62-dodecaoxo-9-{2-[( L-asparaginyl-L-leucyl-L-phenylalanyl-L-glutaminyl-L-valyl-L-valyl-L-histidyl-L-asparaginyl-L-seryl-L-tyrosyl-L-asparaginyl-L-arginyl-L-prolyl-L-alanyl-L-tyrosyl-L-seryl-L-prolylL-prolylglycyl)amino]ethyl}-3lambda(4)-thia-9,12,17,20,23,28,31,34,39,42,45,50,53,56,61-pentadecaazahexahexacontan-66-yl)amino
;
(1-{[3-O-(alpha-L-rhamnosyl)-beta-D-glucosyl]oxy}-20,31,42,53-tetrakis{5-[(2-{[3-O-(alpha-L-rhamnosyl)-beta-D-glucosyl]oxy}ethyl)sulfinyl]pentanoyl}-3-oxido-8,13,16,24,27,35,38,46,49,57,60,62-dodecaoxo-9-{2-[( L-Asn-L-Leu-L-Phe-L-Gln-L-Val-L-Val-L-His-L-Asn-L-Ser-L-Tyr-L-Asn-L-Arg-L-Pro-L-Ala-L-Tyr-L-Ser-L-ProL-Gly)amino]ethyl}-3lambda(4)-thia-9,12,17,20,23,28,31,34,39,42,45,50,53,56,61-pentadecaazahexahexacontan-66-yl)amino
;
Formula=C233H379N44O97S5
;
SMILES=C(C(=O)N)[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N[C@H](C(N[C@@H](CC(=O)N)C(=O)N[C@H](C(N[C@H](C(N[C@@H](CC(=O)N)C(N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(=O)NCC(NCCN(CCNC(CCC(NCCN(CCNC(CCC(NCCN(CCNC(CCC(NCCN(CCNC(CCC(NCCN(CCNC(CCC(NC(CCCCN*)=O)=O)=O)C(CCCCS(=O)CCO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)O)O)=O)=O)=O)C(CCCCS(=O)CCO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O[C@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)C)O)O)O)O)=O)=O)=O)C(CCCCS(=O)CCO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)=O)=O)=O)C(CCCCS(=O)CCO[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O[C@H]%10[C@@H]([C@@H]([C@H]([C@@H](O%10)C)O)O)O)O)=O)=O)=O)C(CCCCS(=O)CCO[C@H]%11[C@@H]([C@H]([C@@H]([C@H](O%11)CO)O)O[C@H]%12[C@@H]([C@@H]([C@H]([C@@H](O%12)C)O)O)O)O)=O)=O)CCC2)=O)CO)=O)CC%13=CC=C(C=C%13)O)=O)C)CCCNC(N)=N)=O)=O)CC%14=CC=C(C=C%14)O)=O)CO)=O)CC=%15N=CNC%15)C(C)C)=O)C(C)C)=O)CCC(=O)N)=O)CC=%16C=CC=CC%16)=O)CC(C)C)=O)N
|
| Xrefs: |
PMID:27091615 |
|
